S. Rakoff-nahoum and R. Medzhitov, Role of toll-like receptors in tissue repair and tumorigenesis, Biochemistry (Moscow), vol.73, issue.5, pp.555-561, 2008.
DOI : 10.1134/S0006297908050088

S. Rakoff-nahoum and R. Medzhitov, Toll-like receptors and cancer, Nature Reviews Cancer, vol.5, issue.1, pp.57-63, 2009.
DOI : 10.1182/blood-2007-05-088682

R. Roses, M. Xu, G. Koski, and B. Czerniecki, Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer, Oncogene, vol.171, issue.2, pp.200-207, 2008.
DOI : 10.1084/jem.20062056

O. Neill, L. Sheedy, F. Mccoy, and C. , MicroRNAs: the fine-tuners of Toll-like receptor signalling, Nature Reviews Immunology, vol.183, issue.3, pp.163-175, 2011.
DOI : 10.1038/nri2957

S. Quinn, O. Neill, and L. , A trio of microRNAs that control Toll-like receptor signalling, International Immunology, vol.23, issue.7, pp.421-425, 2011.
DOI : 10.1093/intimm/dxr034

J. Kluwe, A. Mencin, and R. Schwabe, Toll-like receptors, wound healing, and carcinogenesis, Journal of Molecular Medicine, vol.48, issue.Suppl, pp.125-138, 2009.
DOI : 10.1007/s00109-008-0426-z
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791674

S. Demaria, N. Bhardwaj, W. Mcbride, and S. Formenti, Combining radiotherapy and immunotherapy: A revived partnership, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.3, pp.655-666, 2005.
DOI : 10.1016/j.ijrobp.2005.06.032
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489884

S. Formenti and S. Demaria, Systemic effects of local radiotherapy, The Lancet Oncology, vol.10, issue.7, pp.718-726, 2009.
DOI : 10.1016/S1470-2045(09)70082-8

A. Tesniere, L. Apetoh, F. Ghiringhelli, N. Joza, T. Panaretakis et al., Immunogenic cancer cell death: a key-lock paradigm, Current Opinion in Immunology, vol.20, issue.5, pp.504-511, 2008.
DOI : 10.1016/j.coi.2008.05.007

T. Tallant, A. Deb, N. Kar, J. Lupica, M. De-veer et al., Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells, BMC Microbiology, vol.4, issue.1, p.33, 2004.
DOI : 10.1186/1471-2180-4-33

C. Nempont, D. Cayet, M. Rumbo, C. Bompard, V. Villeret et al., Deletion of Flagellin's Hypervariable Region Abrogates Antibody-Mediated Neutralization and Systemic Activation of TLR5-Dependent Immunity, The Journal of Immunology, vol.181, issue.3, pp.2036-2043, 2008.
DOI : 10.4049/jimmunol.181.3.2036

F. Liu, Y. J. Zhang, Y. Zhou, D. Chen, Y. Gai et al., Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy, Biochemical and Biophysical Research Communications, vol.392, issue.4, pp.582-587, 2010.
DOI : 10.1016/j.bbrc.2010.01.077

M. Vijay-kumar, J. Aitken, C. Sanders, A. Frias, V. Sloane et al., Flagellin Treatment Protects against Chemicals, Bacteria, Viruses, and Radiation, The Journal of Immunology, vol.180, issue.12, pp.8280-8285, 2008.
DOI : 10.4049/jimmunol.180.12.8280

M. Rumbo, C. Nempont, J. Kraehenbuhl, and J. Sirard, Mucosal interplay among commensal and pathogenic bacteria: Lessons from flagellin and Toll-like receptor 5, FEBS Letters, vol.102, issue.12, pp.2976-2984, 2006.
DOI : 10.1016/j.febslet.2006.04.036
URL : https://hal.archives-ouvertes.fr/inserm-00071278

C. Rydberg, A. Månsson, R. Uddman, K. Riesbeck, and L. Cardell, Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas, Immunology, vol.63, issue.1pt2, pp.600-611, 2009.
DOI : 10.1111/j.1365-2567.2008.03041.x

N. Gao, A. Kumar, J. Jyot, and F. Yu, Flagellin-Induced Corneal Antimicrobial Peptide Production and Wound Repair Involve a Novel NF-??B???Independent and EGFR-Dependent Pathway, PLoS ONE, vol.54, issue.2, p.9351, 2010.
DOI : 10.1371/journal.pone.0009351.g009

W. Chao, Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart, AJP: Heart and Circulatory Physiology, vol.296, issue.1, pp.1-12, 2009.
DOI : 10.1152/ajpheart.00995.2008

S. Rhee, E. Im, and C. Pothoulakis, Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer, Gastroenterology, vol.135, issue.2, pp.518-528, 2008.
DOI : 10.1053/j.gastro.2008.04.022

L. Sfondrini, A. Rossini, D. Besusso, A. Merlo, E. Tagliabue et al., Antitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer, The Journal of Immunology, vol.176, issue.11, pp.6624-6630, 2006.
DOI : 10.4049/jimmunol.176.11.6624

L. Burdelya, V. Krivokrysenko, T. Tallant, E. Strom, A. Gleiberman et al., An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models, Science, vol.320, issue.5873, pp.226-230, 2008.
DOI : 10.1126/science.1154986

J. Baines and E. Celis, Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides, Clin Cancer Res, vol.9, pp.2693-2700, 2003.

K. Heckelsmiller, K. Rall, S. Beck, A. Schlamp, J. Seiderer et al., Peritumoral CpG DNA Elicits a Coordinated Response of CD8 T Cells and Innate Effectors to Cure Established Tumors in a Murine Colon Carcinoma Model, The Journal of Immunology, vol.169, issue.7, pp.3892-3899, 2002.
DOI : 10.4049/jimmunol.169.7.3892

Y. Kawarada, R. Ganss, N. Garbi, T. Sacher, B. Arnold et al., NK- and CD8+ T Cell-Mediated Eradication of Established Tumors by Peritumoral Injection of CpG-Containing Oligodeoxynucleotides, The Journal of Immunology, vol.167, issue.9, pp.5247-5253, 2001.
DOI : 10.4049/jimmunol.167.9.5247

A. Krieg, Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides, Current Oncology Reports, vol.21, issue.2, pp.88-95, 2004.
DOI : 10.1007/s11912-004-0019-0

B. Weigel, D. Rodeberg, A. Krieg, and B. Blazar, CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma, Clin Cancer Res, vol.9, pp.3105-3114, 2003.

K. Mason, R. Neal, N. Hunter, H. Ariga, K. Ang et al., CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors, Radiotherapy and Oncology, vol.80, issue.2, pp.192-198, 2006.
DOI : 10.1016/j.radonc.2006.07.024

L. Milas, K. Mason, H. Ariga, N. Hunter, R. Neal et al., CpG Oligodeoxynucleotide Enhances Tumor Response to Radiation, Cancer Research, vol.64, issue.15, pp.5074-5077, 2004.
DOI : 10.1158/0008-5472.CAN-04-0926

K. Mason, H. Ariga, R. Neal, D. Valdecanas, N. Hunter et al., Targeting tolllike receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy, Clin Cancer Res, vol.11, pp.361-369, 2005.

A. Krieg, Development of TLR9 agonists for cancer therapy, Journal of Clinical Investigation, vol.117, issue.5, pp.1184-1194, 2007.
DOI : 10.1172/JCI31414

P. Taylor, M. Ehrhardt, C. Lees, A. Panoskaltsis-mortari, A. Krieg et al., TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection, Blood, vol.112, issue.8, pp.3508-3516, 2008.
DOI : 10.1182/blood-2007-09-113670

J. Fourcade, P. Kudela, A. Filho, P. Janjic, B. Land et al., Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients, Journal of Immunotherapy, vol.31, issue.8, pp.781-791, 2008.
DOI : 10.1097/CJI.0b013e318183af0b

A. Paun, J. Fox, V. Balloy, M. Chignard, S. Qureshi et al., Combined Tlr2 and Tlr4 Deficiency Increases Radiation-Induced Pulmonary Fibrosis in Mice, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.4, pp.1198-1205, 2010.
DOI : 10.1016/j.ijrobp.2009.12.065

K. Nilsson, R. Henriksson, S. Hellström, A. Tengblad, and L. Bjermer, Hyaluronan Reflects the Pre-fibrotic Inflammation in Irradiated Rat Lung: Concomitant Analysis of Parenchymal Tissues and Bronchoalveolar Lavage, International Journal of Radiation Biology, vol.31, issue.3, pp.519-530, 1990.
DOI : 10.1136/thx.42.12.933

P. Teder, R. Vandivier, D. Jiang, J. Liang, L. Cohn et al., Resolution of Lung Inflammation by CD44, Science, vol.296, issue.5565, pp.155-158, 2002.
DOI : 10.1126/science.1069659

D. Rosenbaum, S. Peric, M. Holecek, and H. Ward, Hyaluronan in Radiation-Induced Lung Disease in the Rat, Radiation Research, vol.147, issue.5, pp.585-591, 1997.
DOI : 10.2307/3579625